AOD-9604 research peptide is supplied to qualified Canadian institutions as a characterized laboratory material for in vitro metabolic-pathway and fragment-mapping studies. The compound corresponds to the C-terminal 176–191 region of human growth hormone with an added N-terminal tyrosine (hGH fragment 176-191 analogue).

In vitro, AOD-9604 is used to probe lipolytic and lipid-metabolism readouts that have been attributed to the C-terminal region of hGH, independently of the parent hormone's growth-promoting domain. Typical experimental designs apply the fragment to adipocyte or hepatocyte models and record lipase-pathway markers, gene-expression panels, or receptor-proximal signals that can be compared with full-length hGH and other fragments. The listing describes biochemical use in experimental systems only and does not assign a clinical indication.

The material is offered as a lyophilized vial. Identity data (CAS 221231-10-3, formula C78H123N23O23S2, molecular weight 1815.1 g/mol, PubChem CID 71300630) are listed on the specification table. Store lyophilized at −20 °C, protected from light, and handle under the receiving institution's chemical-hygiene plan.

Lots are sourced from a GMP-aligned peptide manufacturing partner and released against the stated HPLC purity for that lot (≥98% by HPLC, lot-specific). Identity, chromatographic purity, and related analytical results are documented on the lot certificate of analysis (COA). Retain the COA with the inventory record.

This listing is a research-use-only peptide offered to qualified Canadian institutions for in vitro and laboratory use. Purchasing access is limited to verified Canadian research institutions; individual consumer accounts are not accepted. It is not for human or veterinary use, is not intended for diagnostic procedures, and has not been evaluated or authorized by Health Canada as a drug, diagnostic, or medical product.